Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
441.36
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
70
71
Next >
Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow
May 04, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
Earnings Outlook For Vertex Pharmaceuticals
↗
May 02, 2025
Via
Benzinga
S&P Global, Berkshire Hathaway, CME Group And A Health Care Stock: CNBC's 'Final Trades'
↗
May 01, 2025
Via
Benzinga
Topics
Stocks
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential
↗
April 30, 2025
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential
Via
Chartmill
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
↗
April 30, 2025
Via
The Motley Fool
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
↗
April 29, 2025
Via
Benzinga
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
↗
April 28, 2025
Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market
↗
April 28, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Energy
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
↗
April 22, 2025
Via
The Motley Fool
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold
↗
April 22, 2025
Via
The Motley Fool
Topics
Government
Expert Outlook: Vertex Pharmaceuticals Through The Eyes Of 18 Analysts
↗
April 22, 2025
Via
Benzinga
Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right
↗
April 22, 2025
Via
The Motley Fool
Topics
Economy
Government
World Trade
Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely
↗
April 21, 2025
Vertex Pharmaceuticals is expected to report first quarter earnings on May 5, with investor focus on its two big launches and potential upside surprises.
Via
Benzinga
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
↗
April 18, 2025
Via
The Motley Fool
Topics
Government
World Trade
Peering Into Vertex Pharmaceuticals's Recent Short Interest
↗
April 17, 2025
Via
Benzinga
As The Nasdaq 100 Index Crashes, Is It Safe To Buy The Dip?
↗
April 17, 2025
The Nasdaq 100 Index remains under pressure after forming a death cross pattern a few weeks ago. It has retreated to $18,257, down by over 17.8% from its highest point this year.
Via
Talk Markets
Topics
Stocks / Equities
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
↗
April 16, 2025
Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating...
Via
Benzinga
Topics
Government
Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce
↗
April 15, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Government
Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades
↗
April 12, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Stocks
CrowdStrike, Robinhood, Palo Alto Networks And A Health Care Stock On CNBC's 'Final Trades'
↗
April 11, 2025
CrowdStrike has expanded its partnership with Google Cloud to enable end-to-end security for AI innovation.
Via
Benzinga
Topics
Artificial Intelligence
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis
April 11, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
↗
April 11, 2025
Via
The Motley Fool
We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.
↗
April 10, 2025
Via
The Motley Fool
Topics
Economy
Government
World Trade
5 Top Growth Stocks to Buy in the Stock Market Sell-Off
↗
April 09, 2025
Via
The Motley Fool
Topics
Government
Is Vertex Pharmaceuticals Stock a Buy?
↗
April 08, 2025
Via
The Motley Fool
These 5 S&P 500 Winners Held Strong In Q1 — Can The Rally Continue?
↗
April 07, 2025
A group of S&P 500 stocks have remained resilient as tariffs and earnings concerns cause the market to drop. Future gains may be limited.
Via
Benzinga
Topics
Stocks
World Trade
Vertex to Announce First Quarter 2025 Financial Results on May 5th
April 07, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex's Journavx Launch Sparks Optimism, Analyst Sees 'Two Potential Upside Levers'
↗
April 07, 2025
Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.
Via
Benzinga
2 Stocks to Buy if You're Worried About a Recession
↗
April 07, 2025
Via
The Motley Fool
Topics
Economy
Government
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4
April 07, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with United...
Via
StockStory
Topics
Artificial Intelligence
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
70
71
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
